Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 23, 2014, 73 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $62.51 to $8,984,875.00.

Highlighted Stocks Traded by Insiders:

Financial Engines (FNGN) - FREE Research Report

O Donnell Kelly, who is EVP Marketing at Financial Engines, sold 1,250 shares at $38.05 on Dec. 23, 2014. Following this transaction, the EVP Marketing owned 10,961 shares meaning that the stake was reduced by 10.24% with the 1,250-share transaction.

The shares most recently traded at $37.06, down $0.99, or 2.67% since the insider transaction. Historical insider transactions for Financial Engines go as follows:

  • 4-Week # shares sold: 11,111
  • 12-Week # shares sold: 11,111
  • 24-Week # shares sold: 33,333

The average volume for Financial Engines has been 471,200 shares per day over the past 30 days. Financial Engines has a market cap of $2.0 billion and is part of the financial sector and financial services industry. Shares are down 45.61% year-to-date as of the close of trading on Monday.

Financial Engines, Inc., together with its subsidiaries, provides independent, technology-enabled portfolio management services, investment advice, and retirement income services to participants in employer-sponsored defined contribution plans in the United States. The stock currently has a dividend yield of 0.63%. The company has a P/E ratio of 57.0. Currently, there are 2 analysts who rate Financial Engines a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FNGN - FREE

TheStreet Quant Ratings

rates Financial Engines as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and premium valuation. Get the full

Financial Engines Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Progressive (PGR) - FREE Research Report

Charney M Jeffrey, who is Chief Marketing Officer at Progressive, sold 9,000 shares at $26.89 on Dec. 23, 2014. Following this transaction, the Chief Marketing Officer owned 54,860 shares meaning that the stake was reduced by 14.09% with the 9,000-share transaction.

The shares most recently traded at $26.97, up $0.08, or 0.3% since the insider transaction. Historical insider transactions for Progressive go as follows:

  • 4-Week # shares sold: 103,737
  • 12-Week # shares sold: 103,737
  • 24-Week # shares sold: 214,914

The average volume for Progressive has been 3.3 million shares per day over the past 30 days. Progressive has a market cap of $15.6 billion and is part of the financial sector and insurance industry. Shares are down 1.94% year-to-date as of the close of trading on Monday.

The Progressive Corporation, through its subsidiaries, provides personal and commercial automobile insurance, and other specialty property-casualty insurance products and related services primarily in the United States. The stock currently has a dividend yield of 1.86%. The company has a P/E ratio of 13.1. Currently, there is 1 analyst who rates Progressive a buy, 3 analysts rate it a sell, and 13 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PGR - FREE

TheStreet Quant Ratings

rates Progressive as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, notable return on equity, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

Progressive Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mallinckrodt (MNK) - FREE Research Report

Edwards Peter G, who is Sr. VP & General Counsel at Mallinckrodt, sold 1,265 shares at $99.69 on Dec. 23, 2014. Following this transaction, the Sr. VP & General Counsel owned 15,167 shares meaning that the stake was reduced by 7.7% with the 1,265-share transaction.

The shares most recently traded at $98.13, down $1.56, or 1.59% since the insider transaction.

The average volume for Mallinckrodt has been 1.7 million shares per day over the past 30 days. Mallinckrodt has a market cap of $11.6 billion and is part of the health care sector and drugs industry. Shares are up 90.83% year-to-date as of the close of trading on Monday.

Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical products and medical imaging agents worldwide. The company operates through two segments, Specialty Pharmaceuticals and Global Medical Imaging. Currently, there are 8 analysts who rate Mallinckrodt a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MNK - FREE

TheStreet Quant Ratings

rates Mallinckrodt as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share. Get the full

Mallinckrodt Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null